Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Abdul Rouf Mir

University of Kashmir, India

Title: Histone glycoxidation and its role in Cancer autoimmunity

Biography

Biography: Abdul Rouf Mir

Abstract

The emerging correlation of AGE-RAGE axis with cancers has led researchers to study the role of sugars and their by-products as potential relevant mediators. Where, some workers have established the association between hypergycemia and cancer by investigating AGEs in blood circulation, our group has observed a strong autoimmune response against neo-epitopes generated upon histone proteins due to glycoxidation induced structural perturbations. In this study, we report the methylglyoxal induced conformational changes in histone H1 and H2A leading to modifications in the aromatic residues, changed tyrosine microenvironment, intermolecular cross linking and generation of AGEs, masking of hydrophobic patches and a hypsochromic shift in the in ANS specific fluorescence, amorphous aggregation, thermal stability and the formation of Nε-(carboxyethyl)lysine. Modified histones induced high titre antibodies in rabbits and the IgG isolated form sera of rabbits immunized with modified histones exhibited specific binding with their immunogens in Western Blot analysis. IgG isolated from the sera of patients with different types of cancers  showed better recognition for neo-epitopes on the modified histones in ELISA and gel retardation assay, reflecting the presence of circulating autoantibodies in cancer against glycoxidatively modified histones in cancer patients. Keeping in view the role of protein post translational modifications in stimulating cellular and humoral immune responses, methylglyoxal modified histones may also be considered as potential antigenic candidates for eliciting autoimmune response in cancer patients.